Completed
A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686
NCT00721812
- Conditions
- Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +2 more
- Locations
-
- GSK Investigational Site Harrow, Middlesex, United Kingdom